Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology.
about
Propagation of pathological α-synuclein in marmoset brain.Targets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments.Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.Autophagy in neurodegenerative diseases: pathogenesis and therapy.Let's make microglia great again in neurodegenerative disorders.TLR4 and TLR2 activation is differentially associated with age during Parkinson's disease.Role of pattern recognition receptors of the neurovascular unit in inflamm-aging.Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain.Toll-Like Receptor 2 Signaling and Current Approaches for Therapeutic Modulation in Synucleinopathies.Anti-inflammatory Effects of Curcumin in Microglial Cells.Phosphatidyl-Inositol-3 Kinase Inhibitors Regulate Peptidoglycan-Induced Myeloid Leukocyte Recruitment, Inflammation, and Neurotoxicity in Mouse Brain.Toll-like receptor 2 promotes neurogenesis from the dentate gyrus after photothrombotic cerebral ischemia in mice.Evaluation of Serum Apolipoprotein E as a Potential Biomarker for Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease Spectrum of Schizophrenia and Parkinson's disease: A Preliminary StudyImmunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammationMicroglia Response During Parkinson's Disease: Alpha-Synuclein Intervention
P2860
Q37621023-ABDC79DA-844C-48C8-85F1-798B3C0215C6Q39148230-16074414-0093-46F5-9DAA-FCD3661B7674Q39392775-62DF1042-6FE4-427A-8DAF-3FB93DEC03CDQ39432638-6FFB2DB8-9AEA-494A-80C0-05B447D5B33EQ46926746-70A88C6B-2963-4A82-9B2A-0AB4C4D95F6FQ47704026-81304158-0FCA-41A8-B7D6-2AF971A60C5DQ47962378-895009F1-0078-4CC4-96DC-1D0CE9BAD2E2Q51767077-0E89D5E6-5C6F-4D17-B1B5-1FDF1D88E0D3Q54752771-D0C2A9B6-4B16-4F18-ACA0-F5DBF8398BA3Q54979665-45BDF83D-8632-41AB-A625-7512328E1B63Q54979894-A0311FB1-1EEC-431D-BC18-4E16D4FCFCF3Q55100841-46A86BF4-86B6-487B-8D58-C1EFCC2092E8Q57480295-C295A530-77E2-4543-A57E-8A271671C289Q58793525-4B9A65C1-33B2-47C0-94ED-3E23562245A6Q58799080-7C9E79B2-FB28-44B4-9293-F8388B5AC37A
P2860
Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Toll-like receptor 2 is increa ...... to alpha-synuclein pathology.
@en
Toll-like receptor 2 is increa ...... to alpha-synuclein pathology.
@nl
type
label
Toll-like receptor 2 is increa ...... to alpha-synuclein pathology.
@en
Toll-like receptor 2 is increa ...... to alpha-synuclein pathology.
@nl
prefLabel
Toll-like receptor 2 is increa ...... to alpha-synuclein pathology.
@en
Toll-like receptor 2 is increa ...... to alpha-synuclein pathology.
@nl
P2093
P2860
P50
P921
P1476
Toll-like receptor 2 is increa ...... e to alpha-synuclein pathology
@en
P2093
Amanda Gysbers
Amrita Shankar
Anita Bahar
Gayathri Perera
P2860
P2888
P304
P356
10.1007/S00401-016-1648-8
P577
2016-11-25T00:00:00Z